FTC Orders Walmart to Provide Information on Pricing Data Practices
The U.S. Federal Trade Commission has ordered Walmart and other companies to disclose how they utilize consumer data in their pricing and compensation algorithms.
Stocks · News reference
Walmart and Care Access Announce Expansion of Clinical Trial Centers
Walmart Healthcare Research Institute and Care Access plan to open three new Clinical Trial Centers in Michigan, Nevada, and Texas by the first half of 2027.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Home Depot vs. Target: Which Consumer Stock Is a Better Buy in 2026?
The article compares Home Depot and Target as retail investment options for 2026. While Home Depot demonstrates stronger financials with $164.7B revenue and 8.6% net margin, Target is recommended as the better buy due to its lower valuation (P/E 14.6x vs 21.3x), new CEO Michael Fiddelke's $5B transformation initiative showing strong early results (6% sales growth, 35% profit increase in H1 2026), and higher dividend yield of 3.1%. Both stocks face distinct risks including macroeconomic headwinds for Home Depot and operational challenges for Target.
Walmart Announces 2026 Holiday Meal Basket
Walmart has launched its 2026 Holiday Meal Basket, offering a complete meal for 10 people at a price of $35.
Dutch Bros vs. Kimberly-Clark: Which Is the Smarter Buy Today?
The article compares Dutch Bros, a high-growth coffee chain with 27.9% revenue growth, against Kimberly-Clark, a stable consumer staples company with essential products and a 4.65% dividend yield. While Dutch Bros offers expansion potential with locations in fewer than 30 states, the author recommends Kimberly-Clark as the smarter buy in 2026 due to its defensive positioning, recession-resistant business model, and superior performance year-to-date (up 8.1% vs. Dutch Bros down 32%), citing market uncertainty and inflation concerns.